Guardant Health

GH

2 Obserwujący

$41.68

+4.88%

$1.94

Obserwuj

6 Sierpień

Upcoming Earnings

Market Cap.

P/E

Overview Metrics Financials

GH Fair Price

$33.40

Undervalued by 2.3%

Aby wyświetlić sprawiedliwą cenę akcji, musisz być członkiem Bulios Black.

My Notes

Začít psát

Profile

Guardant Health, Inc. is an American biotechnology company specializing in the development of advanced diagnostic tests for cancer detection. The company is known for its liquid biopsy technology, which allows non-invasive analysis of blood samples to identify genetic mutations and biomarkers associated with various types of cancer. Guardant Health focuses on improving early cancer detection, monitoring treatment response, and detecting recurrence, contributing to personalized oncology care and better outcomes for patients.

Feed

There are no posts to show right now.